---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-030552"
form_type: "8-K"
ticker: "ARDT"
cik: "0001756655"
company_name: "Ardent Health, Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:29:15.260114+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ardent Health Q1 2026: Revenue $1.60B (+7%), Adjusted EBITDA $124M (+26%), Reaffirms FY Guidance

## Summary
- Total revenue $1.602B (+7.0% YoY); net income $40M ($0.28 diluted EPS) vs $41M ($0.29) a year ago.
- Adjusted EBITDA $124M (+26.3% YoY); excluding $10.9M gain, growth was 15%.
- Adjusted admissions +2.0%, total surgeries +1.2%; admissions -1.1% due to severe weather and light respiratory season.
- Reaffirmed FY2026 guidance: revenue $6.4–$6.7B, Adj EBITDA $485–$535M, diluted EPS $0.90–$1.27.
- Lease-adjusted net leverage improved to 2.6x from 3.0x a year ago; cash $610M, total debt $1.1B.

## SEC filing metadata
- accession: 0001628280-26-030552
- form_type: 8-K
- ticker: ARDT
- cik: 0001756655
- company_name: Ardent Health, Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/0001628280-26-030552-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/ardt-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-030552
- JSON: https://secwatch.observer/filing/0001628280-26-030552.json
- Plain text: https://secwatch.observer/filing/0001628280-26-030552.txt

## Key facts
- Earnings Releases
  Ardent Health, Inc. reported the first quarter ended March 31, 2026 results: revenue $1,602 million, net income $40 million, EPS $0.28 per diluted share. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2026
  - Revenue: $1,602 million
  - Net income: $40 million
  - EPS: $0.28 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.60 billion 7.0% growth Y/Y Net Income Attributable to Ardent Health $40 million Adjusted EBITDA (1) $124 million 26.3% growth Y/Y Adjusted EBITDAR (1) $166 million Admissions Decrease of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1756655/000162828026030552/0001628280-26-030552-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.